Compounds > simvastatin
Page last updated: 2024-08-23

simvastatin and Autosomal Dominant Hereditary Spastic Paraplegia

simvastatin has been researched along with Autosomal Dominant Hereditary Spastic Paraplegia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carecchio, M; Del Puppo, M; Di Bella, D; Dotti, MT; Magistrelli, L; Mignarri, A; Monti, L1
Del Puppo, M; Dotti, MT; Federico, A; Ginanneschi, F; Magni, A; Malandrini, A; Mignarri, A; Monti, L; Santorelli, FM; Tessa, A2

Other Studies

3 other study(ies) available for simvastatin and Autosomal Dominant Hereditary Spastic Paraplegia

ArticleYear
SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment.
    Journal of the neurological sciences, 2017, 12-15, Volume: 383

    Topics: Adult; Anticholesteremic Agents; Brain; Cytochrome P450 Family 7; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxycholesterols; Middle Aged; Phenotype; Siblings; Simvastatin; Spastic Paraplegia, Hereditary; Steroid Hydroxylases; Treatment Outcome

2017
Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism.
    Journal of neurology, 2014, Volume: 261, Issue:3

    Topics: Adult; Anticholesteremic Agents; Cytochrome P450 Family 7; Female; Humans; Hydroxycholesterols; Male; Mutation; Simvastatin; Spastic Paraplegia, Hereditary; Steroid Hydroxylases; Treatment Outcome; Young Adult

2014
Treatment of SPG5 with cholesterol-lowering drugs.
    Journal of neurology, 2015, Volume: 262, Issue:12

    Topics: Anticholesteremic Agents; Ezetimibe; Follow-Up Studies; Humans; Hydroxycholesterols; Siblings; Simvastatin; Spastic Paraplegia, Hereditary

2015